On August 31, 2022 argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, reported that members of management will participate in a fireside chat at the Wells Fargo Healthcare Conference on Wednesday, September 7, 2022, at 8:00 a.m. E.T. in Boston, MA (Press release, argenx, AUG 31, 2022, View Source [SID1234618831]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of the presentation may be accessed on the Investors section of the argenx website at argenx.com/investors. A replay of the webcast will be available on the argenx website for approximately 90 days following the presentation.

On August 31, 2022 Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, reported that it will present a company update at the H.C. Wainwright 24th Annual Global Investment Conference being held September 12-14, 2022 (Hybrid Conference) (Press release, Anixa Biosciences, AUG 31, 2022, https://ir.anixa.com/news/detail/1000/anixa-biosciences-to-present-at-the-h-c-wainwright-24th-annual-global-investment-conference [SID1234618830]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The presentation will provide an overview of Anixa’s business and highlight recent corporate achievements, including the treatment of the first patient in Anixa’s CAR-T based ovarian cancer clinical trial.

A replay of the presentation will be available for 90 days at the link above or by visiting the Investors section of Anixa’s website at View Source

Anixa management will also be available for one-on-one meetings throughout the conference. Please contact your representative at H.C. Wainwright to request a meeting.

On August 31, 2022 AVEO Oncology (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer, reported that members of its senior management team are scheduled to participate in three investor conferences in September, including (Press release, AVEO, AUG 31, 2022, View Source [SID1234618829]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2022 Wells Fargo Healthcare Conference
Date: Wednesday – Friday, September 7th – 9th
Format: 1×1 Investor Meetings

H.C. Wainwright 24th Annual Global Investment Conference
Date: Monday, September 12th at 5:00 p.m. Eastern Time
Format: Fireside Chat and 1×1 Investor Meetings
Details: A live webcast of the H.C. Wainwright fireside chat can be accessed by visiting the investors section of the Company’s website at www.aveooncology.com. A replay of the webcast will be archived for 90 days following the presentation date.

Baird 2022 Global Healthcare Conference
Date: Tuesday, September 13th at 11:25 a.m. Eastern Time
Format: Presentation and 1×1 Investor Meetings

On August 31, 2022 RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology, reported that members of the RAPT management team will participate in the following investor conferences in September (Press release, RAPT Therapeutics, AUG 31, 2022, https://investors.rapt.com/news-releases/news-release-details/rapt-therapeutics-participate-several-upcoming-investor [SID1234618828]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 17th Annual Biopharma Conference – Investor one-on-ones on Wednesday, September 7, 2022

Wells Fargo Healthcare Conference – Fireside chat with Brian Wong, M.D., Ph.D., RAPT’s President and CEO, on Thursday, September 8, 2022, at 1:55 p.m. ET

H.C. Wainwright 24th Annual Global Investment Conference – Company presentation and panel discussion on autoimmune/inflammatory diseases will be available on-demand on Monday, September 12, 2022
To access the live webcasts or subsequent archived recordings of the company panel discussion and presentations, please visit the RAPT Therapeutics website at https://investors.rapt.com/events-and-presentations.

On August 31, 2022 NuCana plc (NASDAQ: NCNA) reported that management will host one-on-one meetings at Citi’s 17th Annual BioPharma Conference (Press release, Nucana BioPharmaceuticals, AUG 31, 2022, View Source [SID1234618827]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event: Citi’s 17th Annual BioPharma Conference
Dates: September 6-8, 2022
Location: Boston, MA